Skip to content

DR. TRAN, VAATHEELKUNDE

Active Private limited company (pre-2019)founded 2013active for 12 yearsJos De Swertsstraat 60, 2170 AntwerpKBO/BCE: BE 0543.284.033

Lifetime

12 annual accounts with figures on one time axis
peak of €421,763 in 2014
€168,845▼ 51.2%
peak of €229,635 in 2014
€86,137▼ 62.0%
peak of €780,910 in 2024
€640,198▼ 18.0%
€273,604▼ 7.5%
Board1 name since 2013
1 director
Documentsfilings and deeds
29-07-20262 days before the deadline
2025micro format
Gross margin from €345,930 to €168,845Result from €226,848 to €86,137Dividend €226,848Equity from €780,910 to €640,198Cash from €52,359 to €25,118

Key points

from the 2025 annual accounts

Equity

€640,198 ▼ 18.0%
780,9102024+86,137Profit-226,848Dividend640,1982025

DR. TRAN, VAATHEELKUNDE paid out €226,848 in dividends. That is 263% of the 2025 profit.

Result

€86,137 ▼ 62.0%
€227,0002024€86,1002025

The result fell in 2025 from €226,848 to €86,137.

Filings

12 annual accounts since 2014
AprilJune31 JulyOctober201520202025

Eight of the last ten came late. The 2022 accounts came in latest, 31 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,817 companies had the same profile as DR. TRAN, VAATHEELKUNDE has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,817 companies, not a prediction for DR. TRAN, VAATHEELKUNDE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager, since 11-12-2013
  • founderdeed of 30-12-2013
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0543284033
Registered office moved within Merksem The registered office moved from Houthulststraat 183 bus 2, 2170 MERKSEM to Jos de Swertstraat 60, 2170 MERKSEM · Board meeting of 02-01-2017 · Gazette deed
Registered office moved from Rumst to Merksem The registered office moved from Pieter Breughellaan 8 te 2840 Rumst to Houthulststraat 183 bus 2 2170 Merksem · Board meeting of 16-02-2015 · Gazette deed
New establishment in Antwerp DR. TRAN VAATHEELKUNDE, Bredabaan 634
All 25 events

Official details

Source: KBO
Status
Active since 11-12-2013Normal situation
Activity
Specialist medical practiceNACE 862201 activities on the establishment unitsFrom the articles, 4 activities
Establishment units
2.226.972.6192170 Antwerp, since 11-12-2013
2.231.512.7142170 Antwerp, since 13-05-2014
Financial year end
31 December
Peppol
Reachable since 12-01-2026
Company details

Annual accounts 2025

≈ €420,000estimated
€913,802▼ 15.1%
Filing
Filed on 29-07-2026, 2 days before the end of the filing period
Financials

Insights on DR. TRAN, VAATHEELKUNDE

DR. TRAN, VAATHEELKUNDE files the micro format. That format states no turnover. The gross margin fell from €421,763 in 2014 to €168,845 in 2025.

The balance sheet grew most from 2021 to 2023 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. TRAN, VAATHEELKUNDE

What is the company number of DR. TRAN, VAATHEELKUNDE?
The company number of DR. TRAN, VAATHEELKUNDE is 0543.284.033. The VAT number is the same number with BE in front: BE 0543.284.033.
Where is DR. TRAN, VAATHEELKUNDE based?
The registered office is at Jos De Swertsstraat 60, 2170 Antwerp.Company details
What does DR. TRAN, VAATHEELKUNDE do?
According to the KBO register, the main activity of the first establishment unit is specialist medical practice (NACE 86220).
What is the legal form of DR. TRAN, VAATHEELKUNDE?
DR. TRAN, VAATHEELKUNDE is a private limited company (pre-2019) (BVBA).
When was DR. TRAN, VAATHEELKUNDE founded?
DR. TRAN, VAATHEELKUNDE was founded on 11-12-2013.
Is DR. TRAN, VAATHEELKUNDE still active?
Yes, DR. TRAN, VAATHEELKUNDE is an active enterprise in the KBO register.
What is the turnover of DR. TRAN, VAATHEELKUNDE?
The turnover in financial year 2025 is about €420,000. This figure is estimated from the gross margin of €168,845 and 2,452 comparable companies of the same size. It probably lies between €280,000 and €650,000. It is a rough estimate.Financials
Is DR. TRAN, VAATHEELKUNDE profitable?
In financial year 2025, DR. TRAN, VAATHEELKUNDE made a profit of €86,137.
Where can I find the annual accounts of DR. TRAN, VAATHEELKUNDE?
DR. TRAN, VAATHEELKUNDE filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. TRAN, VAATHEELKUNDE due?
DR. TRAN, VAATHEELKUNDE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.